Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials

• Published in: Scientific reports 2022-03, Vol.12 (1), p.3875-3875, Article 3875
• Main Authors: Mittal, Nupur, Saha, Aniket, Avutu, Viswatej, Monga, Varun, Freyer, David R., Roth, Michael
• Format: Article
• Language: English
• Subjects: 692/4028; 692/700; Adolescent; Adolescents; Cancer; Child; Clinical trials; Clinical Trials as Topic; Communication; Cross-Sectional Studies; Demography; Humanities and Social Sciences; Humans; Medical Oncology; multidisciplinary; Neoplasms - therapy; Oncology; Patient Selection; Pediatrics; Science; Science (multidisciplinary); Young Adult; Young adults
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-07703-5

Adolescent and young adult (AYA) enrollment in cancer clinical trials (CCT) is suboptimal. Few studies have explored site level barriers and facilitators to AYA enrollment on CCTs and the efficacy of interventions to enhance enrollment. A cross sectional survey was developed by the COG AYA Oncology Discipline Committee Responsible Investigator (RI) Network to identify perceived barriers and facilitators to enrollment, as well as opportunities to improve enrollment. Associations of barriers and facilitators to enrollment with program demographics were assessed. The survey was sent to all AYA RI Network members (n = 143) and quantitative and thematic analyses were conducted. The overall response rate was 42% (n = 60/143). Participants represented diverse institutions based on size, presence or absence of dedicated AYA programs, and proximity and relationship between pediatric and medical oncology practices within the institution. The most frequently cited barriers to enrolling AYAs in CCTs were administrative logistical issues (45%), disparate enrollment practices (42%) and communication issues (27%) between pediatric and medical oncology and perceived limited trial availability (27%). The most frequently reported facilitators to enrollment included having strong communication between pediatric and medical oncology (48%), having a supportive research infrastructure (35%) and the presence of AYA champions (33%). Many barriers and facilitators were similar across institutions and AYA program types. Shared barriers and facilitators to AYA CCT enrollment exist across the landscape of cancer care settings. Interventions aimed at increasing coordination between pediatric and medical oncology clinical trials offices and providers have high potential to improve site-level AYA enrollment.